Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

Peer Review reports

Original Submission
10 Aug 2013	Submitted	Original manuscript
4 Sep 2013	Reviewed	Reviewer Report - Tim Clarner
18 Sep 2013	Reviewed	Reviewer Report - Markus Kipp
1 Oct 2013	Author responded	Author comments - Deepak Balak
Resubmission - Version 2
1 Oct 2013	Submitted	Manuscript version 2
Publishing
3 Oct 2013	Editorially accepted
16 Oct 2013	Article published	10.1186/1471-2377-13-146

Back to article page